LOGIN  |  REGISTER
Cue Biopharma
Assertio

LifeMD to Participate in Upcoming Investor Conferences and Panel Discussions

November 10, 2023 | Last Trade: US$5.10 0.12 -2.30

NEW YORK, Nov. 10, 2023 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that management will be participating in two upcoming investor conferences and a panel discussion.

  • Cantor Fitzgerald GLP-1 Panel: Payor vs. Provider Perspective, November 13, 2023. Justin Schreiber, Chief Executive Officer of LifeMD, will participate in a panel discussion with Andrew Baskin, M.D., Independent Consultant and formerly the Vice President, National Medical Director at Aetna, Inc. regarding their perspectives on GLP-1s.
  • BTIG Digital Health Forum, November 21, 2023. Mr. Schreiber will participate in a panel discussion titled “Using the Platform Approach” at 12:00 p.m. Eastern time and will be available for one-on-one virtual meetings.
  • Sidoti’s Small-Cap Virtual Conference, December 6-7, 2023. Management will be presenting a corporate overview and will be hosting one-on-one meetings with investors. To register for the conference, visit www.sidoti.com/events. Registration is free and investors are not required to be a Sidoti client.

About LifeMD, Inc.
LifeMD is a leading provider of virtual primary care. LifeMD offers telemedicine, laboratory and pharmacy services, and specialized treatment across more than 200 conditions, including primary care, men’s health, women’s health, allergy & asthma, and dermatology. Leveraging a vertically-integrated, proprietary digital care platform, a 50-state affiliated medical group, and a US-based patient care center, LifeMD is elevating healthcare by increasing access to top-notch and affordable care. For more information, please visit LifeMD.com.

Company Contact
LifeMD, Inc.
Marc Benathen, CFO
This email address is being protected from spambots. You need JavaScript enabled to view it.

Media Contact
This email address is being protected from spambots. You need JavaScript enabled to view it.


Viking Therapeutics

Stock Quote

Featured Stock

ClearPoint Neuro

ClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...

CLICK TO LEARN MORE

Featured Stock

Astria Therapeutics

Astria Therapeutics is a biopharmaceutical company, and our mission is to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Our lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in clinical development...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page

COPYRIGHT ©2023 HEALTH STOCKS HUB